Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trial

Fig. 4

Changes in KSCRS after intra-articular injection of ELIXCYTE® or HA at each time point. KSCRS objective knee indicators (a), symptoms (b), patient satisfaction (c), and functional activities (d) scores are presented as mean ± SD. 16 M, 32 M, 64 M, and HA = 16, 32, 64 million of ELIXCYTE®, and hyaluronic acid, respectively; The signs of significance = *, #, $, &, § representing a p-value < 0.05 between baseline and posttreatment score comparison for HA, 16 M, 32 M, 64 M, and Pooled group

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512